Breaking News on Supplements, Health & Nutrition - Europe US edition | APAC edition

News > Research

Read more breaking news



Vitamin D supplements backed to slash diabetic heart disease risk

2 commentsBy Nathan Gray , 19-Nov-2012
Last updated on 22-Nov-2012 at 18:30 GMT2012-11-22T18:30:26Z

Vitamin D supplements backed to cut diabetic heart risk

Low levels of vitamin D may be responsible for the increased risk of heart disease among diabetic people developing clogged up arteries, according to new research.

The study – published in the Journal of Biological Chemistry – reports that diabetic people who receive good levels of vitamin D are less likely to develop atherosclerotic plaques that clog up blood vessels, while people with low levels of the sunshine vitamin are at higher risk of developing clogged up blood vessels.

Led by Carlos Bernal-Mizrachi from Washington University School of Medicine, the research team suggest low vitamin D levels may be to blame for the higher risk of heart disease often seen in people with diabetes.

"As obesity rates rise, we expect even more people will develop diabetes,” said Bernal-Mizrachi. “Those patients are more likely to experience heart problems due to an increase in vascular inflammation, so we have been investigating why this occurs."

The researchers explained that the new study builds on previous findings from the group by not only suggesting that vitamin D is implicated in the risk of heart disease for diabetic people, but also that when vitamin D levels are low, a particular class of white blood cells known as macrophages are more likely to adhere to cells in the walls of blood vessels.

As a result, the authors suggest that vitamin D levels work to influence these immune cells to either keep arteries clear or to clog them.

Study details

Bernal-Mizrachi and his team investigated the vitamin D levels in 43 people with type 2 diabetes and in 25 others who were similar in age, sex and body weight but didn't have diabetes.

They found that in diabetes patients with low vitamin D — defined as less than 30 nanograms per milliliter of blood — macrophage cells were more likely to adhere to the walls of blood vessels. This then triggers cells to load with cholesterol, and eventually causes the vessels to stiffen and block blood flow.

"We took everything into account," said first author Dr Amy Riek. "We looked at blood pressure, cholesterol, diabetes control, body weight and race. But only vitamin D levels correlated to whether these cells stuck to the blood vessel wall."

However, both Riek and Bernal-Mizrachi said what is not yet clear is whether giving vitamin D to people with diabetes will reverse their risk of developing atherosclerosis.

The team said they are now treating mice with vitamin D to see whether it can prevent immune cells from adhering to the walls of blood vessels near the heart, and are also conducting two clinical trials in patients.

In one of those studies, the researchers are giving vitamin D to people with diabetes and hypertension to see whether the treatment may lower blood pressure.

In the second study, African Americans with type 2 diabetes are receiving vitamin D along with their other daily medications, and the research team is evaluating whether vitamin D supplements can slow or reverse the progression of heart disease.

The full study can be found here.

2 comments (Comments are now closed)

A Title for the Mainstream Media

Is this just an error or the typical distortion like in the MSM to marginalize the Supplements market? It would also add to credibility when you add references and who financed the "study".

Report abuse

Posted by Heinz Gisel
21 November 2012 | 21h362012-11-21T21:36:10Z

Wrong title

1. The title and the content of this article contradict each other.
2. Let's not forget about citing some reference next time.

Report abuse

Posted by Laszlo G Meszaros
20 November 2012 | 06h022012-11-20T06:02:52Z

Related products

Live Supplier Webinars

Polyphenols tipped to become the way to innovate in Sports Nutrition
Orally bioavailable standardized botanical derivatives in sport nutrition: special focus on recovery in post-intense physical activities
Collagen in motion: move freely and keep your injuries in check
Leading manufacturer of gelatine and collagen peptides
Life’s too short for slow proteins. Whey proteins hydrolysates: Fast delivery for enhanced performance
Arla Foods Ingredients
What it Takes to Compete and Win in Today’s Sports Nutrition Market
Sports Nutrition Snapshot: Key regional drivers and delivery format innovations
William Reed Business Media
Gutsy performance: How can microbiome modulation help athletes and weekend warriors
William Reed Business Media
Pushing the boundaries: Where’s the line between ‘cutting edge nutrition’ and doping
William Reed Business Media
Alpha & Omega in Sports Nutrition – Using Omega 3’s and A-GPC to improve performance and recovery.
KD Pharma

On demand Supplier Webinars

High-amylose maize starch may reduce the risk of type 2 diabetes: what does this qualified health claim mean?
Balancing Innovation and Risk in Sports Nutrition Ingredients
Explaining bio-hacking: is there a marketing opportunity for food companies?
William Reed Business Media
Personalized Nutrition – how an industry can take part in shaping the future of Nutrition
BASF Nutrition & Health
Find out Nutritional and ingredient lifecycle solutions and strategies!
Is the time rIpe for I-nutrition?
William Reed Business Media
The Advantage of Outsourcing Fermentation-based Manufacturing Processes
Evonik Health Care
All supplier webinars